首页> 外文OA文献 >A Unified Analytic Framework for Prioritization of Non-Coding Variants of Uncertain Significance in Heritable Breast and Ovarian Cancer
【2h】

A Unified Analytic Framework for Prioritization of Non-Coding Variants of Uncertain Significance in Heritable Breast and Ovarian Cancer

机译:对遗传性乳腺癌和卵巢癌中不确定性的非编码变体进行优先级排序的统一分析框架

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundSequencing of both healthy and disease singletons yields many novel and low frequency variants of uncertain significance (VUS). Complete gene and genome sequencing by next generation sequencing (NGS) significantly increases the number of VUS detected. While prior studies have emphasized protein coding variants, non-coding sequence variants have also been proven to significantly contribute to high penetrance disorders, such as hereditary breast and ovarian cancer (HBOC). We present a strategy for analyzing different functional classes of non-coding variants based on information theory (IT) and prioritizing patients with large intragenic deletions.MethodsWe captured and enriched for coding and non-coding variants in genes known to harbor mutations that increase HBOC risk. Custom oligonucleotide baits spanning the complete coding, non-coding, and intergenic regions 10 kb up- and downstream of ATM, BRCA1, BRCA2, CDH1, CHEK2, PALB2, and TP53 were synthesized for solution hybridization enrichment. Unique and divergent repetitive sequences were sequenced in 102 high-risk, anonymized patients without identified mutations in BRCA1/2. Aside from protein coding and copy number changes, IT-based sequence analysis was used to identify and prioritize pathogenic non-coding variants that occurred within sequence elements predicted to be recognized by proteins or protein complexes involved in mRNA splicing, transcription, and untranslated region (UTR) binding and structure. This approach was supplemented by in silico and laboratory analysis of UTR structure.Results15,311 unique variants were identified, of which 245 occurred in coding regions. With the unified IT-framework, 132 variants were identified and 87 functionally significant VUS were further prioritized. An intragenic 32.1 kb interval in BRCA2 that was likely hemizygous was detected in one patient. We also identified 4 stop-gain variants and 3 reading-frame altering exonic insertions/deletions (indels).ConclusionsWe have presented a strategy for complete gene sequence analysis followed by a unified framework for interpreting non-coding variants that may affect gene expression. This approach distills large numbers of variants detected by NGS to a limited set of variants prioritized as potential deleterious changes.
机译:背景对健康和疾病单例的测序会产生许多不确定意义(VUS)的新颖和低频变异。通过下一代测序(NGS)进行完整的基因和基因组测序会大大增加检测到的VUS数量。尽管先前的研究强调蛋白质编码变体,但非编码序列变体也已被证明可显着促进高渗透性疾病,例如遗传性乳腺癌和卵巢癌(HBOC)。我们提出了一种基于信息论(IT)来分析非编码变异的不同功能类别的策略,并对具有较大基因内缺失的患者进行优先排序。方法我们捕获并丰富了已知具有可能增加HBOC风险的突变的基因中的编码和非编码变异。合成了跨越ATM,BRCA1,BRCA2,CDH1,CHEK2,PALB2和TP53的ATM上游和下游10 kb完整编码区,非编码区和基因间区的定制寡核苷酸诱饵,用于溶液杂交富集。在102名高风险,匿名患者中未发现BRCA1 / 2突变的情况下,对独特且不同的重复序列进行了测序。除了蛋白质编码和拷贝数变化以外,基于IT的序列分析还用于识别和区分致病性非编码变异,这些变异发生在预测被mRNA剪接,转录和非翻译区所涉及的蛋白质或蛋白质复合物识别的序列元件内( UTR)的绑定和结构。通过计算机和UTR结构的实验室分析对该方法进行了补充。结果鉴定出15,311个独特变体,其中245个发生在编码区。借助统一的IT框架,确定了132个变体,并进一步确定了87个功能重大的VUS的优先级。在一名患者中检测到BRCA2的基因内32.1 kb间隔,可能是半合子。我们还鉴定了4个终止增益变异体和3个阅读框改变外显子插入/缺失(indels)。结论我们提出了完整基因序列分析的策略,然后提出了一个统一的框架来解释可能影响基因表达的非编码变异体。这种方法将NGS检测到的大量变体提炼成有限的一组变体,这些变体被优先考虑为潜在的有害变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号